⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001831341

Chiang Kyle

Reports to the SEC for 1 company · LEXINGTON, MA

Transactions

5

Companies

1

Filings

3

CIK

0001831341

Forms 4 and 5

Insider transactions

5 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-16	LogicBio Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,977 sh	$5.73	−$17.1K	23,387
2021-04-15	LogicBio Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+9,360 sh	—	—	26,364
2021-04-15	LogicBio Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−9,360 sh	—	—	0
2021-02-23	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+156K sh	—	—	155,701
2020-11-02	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+85K sh	—	—	85,000

Recent filings

3

Accepted (ET)
Apr 194
Chiang Kyle0001209191-21-027460
SEC(opens sec.gov)
Feb 254
Chiang Kyle0001209191-21-014478
SEC(opens sec.gov)
Nov 124
Chiang Kyle0001209191-20-058171
SEC(opens sec.gov)

Companies

1

LogicBio Therapeutics, Inc.Chief Operating Officer

Address

C/O LOGICBIO THERAPEUTICS, INC. 65 HAYDEN AVE, FLOOR 2

LEXINGTON, MA, 02421